The use of a quadripolar left ventricular lead increases successful implantation rates in patients with phrenic nerve stimulation and/or high pacing thresholds undergoing cardiac resynchronisation therapy with conventional bipolar leads

Indian Pacing and Electrophysiology Journal

Volumn 13, Issue 2, 2013, Pages 58-65

  Ohlow, Marc Alexander ^a   Lauer, Bernward ^a   Brunelli, Michele ^a   Daralammouri, Yunis ^a   Geller, J Christoph ^a  

^a ZENTRALKLINIK BAD BERKA   (Germany)

Author keywords

Cardiac resynchronisation therapy; Lead; Phrenic nerve stimulation; Quadripolar; Threshold

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR EQUIPMENT; CHRONIC DISEASE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE; HEART VENTRICLE PACING; HIGH PACING THRESHOLD; HUMAN; IMPLANTATION; INTRAOPERATIVE PERIOD; ISCHEMIC HEART DISEASE; MALE; NERVE STIMULATION; PHRENIC NERVE PACING; QRS COMPLEX; QUADRIPOLAR LEFT VENTRICULAR LEAD; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

EID: 84875188775     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: 10.1016/S0972-6292(16)30605-2     Document Type: Article

References (17)

1. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.
2. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
3. Abraham WT, Fisher WG, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
4. Daoud EG, Kalbfleisch SJ, Hummel JD, et al. Implantation techniques and chronic lead parameters of biventricular pacing dual chamber defibrillators. J Cardiovasc Electrophysiol 2002;13:964-970.
5. Bisch L, Da Costa A, Dauphinot V, et al. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy. Europace 2010;12:1141-1148.
6. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
7. Gurevitz O, Nof E, Carasso S, et al. Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol 2005;28:1255-1259.
8. Seifert M, Schau T, Moeller V, Neuss M, Meyhoefer J, Butter C. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy. Europace 2010;12:961-967.
9. Vardas PE, Auricchio A, Blanc JJ, ez al. European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 2007;9:959-98.
10. Dickstein K, Vardas PE, Auricchio A, et al. Committee for Practice Guidelines of the European Society of Cardiology. 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail 2010;12:1143-53.
11. Crossley GH, Exner D, Mead RH, et al. Chronic performance of an active fixation coronary sinus lead. Heart Rhythm 2010;7:472-8.
12. Biffi M, Moschini C, Bertini M, et al. Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2009;2:402-10.
13. Klein N, Klein M, Weglage H, et al. Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronisation therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: insights from the Efface Phrenic Stim study. Europace 2012;14:826-832.
14. Shetty A, Duckett S, Bostok J, Rosenthal E, Rinaldi C. Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronisation therapy. Europace 2011;13(7):992-996.
15. Shetty A, Duckett S, Bostok J, et al. Initial Single-Center Experience of a Quadripolar Pacing Lead for Cardiac Resynchronization Therapy. PACE 2011;34:484-489.
16. Sperzel J, Dänschel W, Gutleben K, et al. First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead. Europace 2012;14:365-372.
17. Sterliński M, Maciag A, Kowalik I, et al. Success rate of transvenous left ventricular lead implantation for cardiac resynchronisation therapy - recent experience of a single centre. Kardiol Pol. 2010;68(8):903-9.